Advertisement

Scientists using algae to produce low-cost COVID-19 test kits

Follow The Hawk on Google News+ Follow

Advertisement


Researchers in Canada are using algae to rapidly develop low-cost serological test kits for COVID-19 that they say would determine if someone has been infected with the novel coronavirus.

The new method overcomes shortfalls of existing processes while saving money, according to the researchers from the University of Western Ontario in Canada.

Advertisement

The team collaborated with Canadian integrated energy company Suncor to develop algae as a production factory to make necessary proteins to identify COVID-19 antibodies in someone previously infected with the disease.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"We are using a microalgae that shows a lot of promise for not only producing the protein needed, but producing it with the correct modifications to mimic how it's made in humans," Daniel Giguere from the University of Western Ontario said in a statement.

"We are leveraging our in-house expertise and technology to rapidly produce the proteins and validate their effectiveness as a testing reagent," Sam Slattery from the university added.

Advertisement

The researchers noted that one of the limiting factors in developing large-scale serological testing is the ability to make significant quantities of the viral proteins on a cost-effective basis.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

Current tests rely on proteins made in reagents such as insect or mammalian cells which are expensive and difficult to scale, they said.

According to the researchers, algae are cheap to grow and can easily be engineered to produce the viral proteins.

"The synthetic biology group at Western has been developing genetic tools for algae that are proving their utility," explained Dave Edgell, co-principal investigator.

The funding has enabled the team to significantly speed up the production process, with test kits expected on the market in a couple of months, said Martin Flatley, Suncor senior staff engineer.

"We already had the equipment, expertise and access to the Western bio-safety lab. We thought, 'How can we use what we developed together to fight COVID-19?" Flatley said.

—PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST